Daniel J. O'Connor
2015 - Advaxis
In 2015, Daniel J. O'Connor earned a total compensation of $12.3M as Former President and Chief Executive Officer at Advaxis.
Compensation breakdown
| Bonus | $170,625 |
|---|---|
| Option Awards | $11,790,326 |
| Salary | $345,986 |
| Other | $29,494 |
| Total | $12,336,431 |
O'Connor received $11.8M in option awards, accounting for 96% of the total pay in 2015.
O'Connor also received $170.6K in bonus, $346K in salary and $29.5K in other compensation.
Rankings
In 2015, Daniel J. O'Connor's compensation ranked 341st out of 13,638 executives tracked by ExecPay. In other words, O'Connor earned more than 97.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 341 out of 13,638 | 98th |
Division Manufacturing | 119 out of 5,190 | 98th |
Major group Chemicals And Allied Products | 51 out of 1,854 | 97th |
Industry group Drugs | 42 out of 1,528 | 97th |
Industry Pharmaceutical Preparations | 35 out of 1,182 | 97th |
Source: SEC filing on February 6, 2018.
O'Connor's colleagues
We found three more compensation records of executives who worked with Daniel J. O'Connor at Advaxis in 2015.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018